Advanced Biomed Inc. Common Stock (NASDAQ:ADVB) — Market Cap & Net Worth
Market Cap & Net Worth: Advanced Biomed Inc. Common Stock (ADVB)
Advanced Biomed Inc. Common Stock (NASDAQ:ADVB) has a market capitalization of $10.42 Million ($10.42 Million) as of September 25, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #27048 globally and #5608 in its home market, demonstrating a -18.26% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Advanced Biomed Inc. Common Stock's stock price $6.31 by its total outstanding shares 1652133 (1.65 Million). Also see Advanced Biomed Inc. Common Stock total assets for a full breakdown of the balance sheet.
Advanced Biomed Inc. Common Stock Market Cap History: 2025 to 2026
Advanced Biomed Inc. Common Stock's market capitalization history from 2025 to 2026. Data shows growth from $482.09K to $10.42 Million (42.33% CAGR). Also see ADVB cash generation efficiency for how efficiently the company converts equity into cash flow.
Index Memberships
Advanced Biomed Inc. Common Stock is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.64 Trillion | 0.00% | #768 of 976 |
Weight: Advanced Biomed Inc. Common Stock's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Advanced Biomed Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Advanced Biomed Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Advanced Biomed Inc. Common Stock share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of ADVB by Market Capitalization
Companies near Advanced Biomed Inc. Common Stock in the global market cap rankings as of September 25, 2026. Review how tangible is Advanced Biomed Inc. Common Stock's equity to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Advanced Biomed Inc. Common Stock by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #89 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #154 globally with a market cap of $158.06 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #464 globally with a market cap of $58.78 Billion USD ( CN¥401.66 Billion CNY).
- Natera Inc (NASDAQ:NTRA): Ranked #577 globally with a market cap of $47.01 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #89 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $678.39 |
| #154 | Danaher Corporation | NYSE:DHR | $158.06 Billion | $223.77 |
| #464 | WuXi AppTec Co Ltd | SHG:603259 | $58.78 Billion | CN¥162.40 |
| #577 | Natera Inc | NASDAQ:NTRA | $47.01 Billion | $408.79 |
Advanced Biomed Inc. Common Stock Historical Marketcap From 2025 to 2026
Between 2025 and today, Advanced Biomed Inc. Common Stock's market cap moved from $482.09K to $ 10.42 Million, with a yearly change of 42.33%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $10.42 Million | +2062.44% |
| 2025 | $482.09K | -- |
End of Day Market Cap According to Different Sources
On Sep 25th, 2026 the market cap of Advanced Biomed Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $10.42 Million USD |
| MoneyControl | $10.42 Million USD |
| MarketWatch | $10.42 Million USD |
| marketcap.company | $10.42 Million USD |
| Reuters | $10.42 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Advanced Biomed Inc. Common Stock
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, an automated sample preparation system that enables pre-concentration of diluted blood samples; AC-1000, a rare cell device to solve the problem of detection of hypercoagul… Read more